Skin Samples May Aid Early Diagnosis of Parkinson’s, Study Suggests
A new method, originally developed to diagnose mad cow disease, shows effectiveness in measuring the buildup of alpha-synuclein…
Articles by Patricia Inácio, PhD
Non-invasive OpsisDx Diagnostic Test Awarded US Academy Research Grant
The Healthy Longevity Global Grand Challenge, founded by the U.S. National Academy of Medicine, has awarded a grant…
Imbalance of Fat Content in Brain Cells May Fuel Parkinson’s Progression, Study Asserts
In patients with Parkinson’s disease, dopamine-producing neurons and microglia cells — the “immune cells” of the brain…
New Software Tool Aids Early Diagnosis of Parkinson’s Disease Psychosis
PointClickCare has developed a new software tool to aid in the early diagnosis of Parkinson’s disease psychosis. The…
FDA to Review Nuplazid as Treatment for Dementia-related Psychosis
The U.S. Food and Drug Administration (FDA) will review Acadia Pharmaceutical’s application asking that Nuplazid (pimavanserin) also be approved…
Phase 3 Trial Tests PhotoPharmics’ At-home Light Therapy to Ease Parkinson’s Symptoms
A new Phase 3 clinical trial will test PhotoPharmics‘ light-based, at-home therapy device — called Celeste — for Parkinson’s disease.
New Insight May Unveil Ways to Lessen Side Effects of Deep Brain Stimulation in Parkinson’s Patients
Distinct connections between nerve cells in the brain may explain why some Parkinson’s disease patients develop impulsivity and behavioral…
Deep Brain Stimulation Not Linked to Greater Risk of Dementia for Parkinson’s Patients, Study Concludes
Long-term deep brain stimulation (DBS) is cognitively safe and does not increase the risk for dementia in people with…
Ongentys Approved in Japan as Levodopa Add-on Therapy for ‘Off’ Periods
Ongentys (opicapone) has been approved in Japan as an oral, add-on daily treatment for Parkinson’s disease patients experiencing off periods while…
$2.2M Grant Awarded to University of Buffalo to Develop Strategy for Early Parkinson’s Diagnosis
The University at Buffalo has received a $2.2 million grant from the National Institute of Neurological Disorders and…